StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) income statement

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3072% above fair value
$21.12−0.27 (-1.26%)

Close on Nov 20, 2026Market cap $6.74BP/E 43.1Yield –

Amneal Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?